SCHEMBL22928261

SCHEMBL22928261

CC(C)(C)c1cccc(NS(=O)(=O)CC(F)(F)F)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.48
CYP2C19 P33261 3/20 0.48
CYP1A2 P05177 1/20 0.48
MAPT P10636 1/20 0.48
MAPK1 P28482 1/20 0.48
CDK1 P06493 2/20 0.46
CCNB1 P14635 2/20 0.46
CCNA2 P20248 2/20 0.46
CDK2 P24941 2/20 0.46
CDK7 P50613 2/20 0.46
CCNH P51946 2/20 0.46
CCNA1 P78396 2/20 0.46
FFAR1 O14842 1/20 0.46
FFAR4 Q5NUL3 1/20 0.46
LRRK2 Q5S007 1/20 0.46
CCND1 P24385 1/20 0.45
CDK6 Q00534 1/20 0.45
RORC P51449 1/20 0.44
HSD17B1 P14061 1/20 0.44
HSD17B2 P37059 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8274370 0.84 NR3C2 (0.57) CYP3A4CYP2C19CYP1A2MAPTMAPK1
SCHEMBL16658362 0.80 RORC (0.47) CYP3A4CYP2C19CYP1A2MAPTMAPK1
SCHEMBL22928260 0.80 CA2 (0.58) CYP3A4CYP2C19CYP1A2MAPTMAPK1
SCHEMBL22619095 0.78 HSD17B1 (0.46) CDK1CCNB1CCNA2CDK2CDK7
SCHEMBL18595673 0.78 SLC22A12 (0.45) CYP3A4LRRK2ALDH1A1CYP2C9
SCHEMBL16658363 0.78 BRD4 (0.49) RORCIKBKBUQCRBNR3C2ALDH1A1
SCHEMBL4403147 0.77 NR3C2 (0.54) CYP3A4CYP2C19CYP1A2MAPTMAPK1
SCHEMBL13935835 0.77 UQCRB (0.49) CYP3A4CYP2C19CYP1A2MAPTMAPK1
SCHEMBL10622850 0.77 KMT2A (0.47) LRRK2HSD17B1HSD17B2CA1CA2
SCHEMBL22928007 0.77 EPHA3 (0.43) CYP3A4CYP2C19CYP1A2MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210024498-A1 TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF MEDICONNS SHANGHAI BIOPHARMACEUTICAL CO LTD (CN) 2021-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024498-A1 TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF PRLHR, DRD2, AVPR2 CYP3A4 542/4885CYP2C19 719/4885CYP1A2 1137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.